Free Trial

Jefferies Financial Group Inc. Purchases Shares of 20,091 Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Sabra Health Care REIT logo with Finance background

Jefferies Financial Group Inc. purchased a new stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 20,091 shares of the real estate investment trust's stock, valued at approximately $348,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. VSM Wealth Advisory LLC bought a new position in Sabra Health Care REIT in the fourth quarter valued at approximately $26,000. Assetmark Inc. raised its position in Sabra Health Care REIT by 33.4% during the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock worth $45,000 after acquiring an additional 656 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Sabra Health Care REIT by 208.3% in the fourth quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust's stock valued at $108,000 after acquiring an additional 4,204 shares during the last quarter. FIL Ltd raised its holdings in shares of Sabra Health Care REIT by 40.4% in the 4th quarter. FIL Ltd now owns 6,512 shares of the real estate investment trust's stock valued at $113,000 after purchasing an additional 1,873 shares during the period. Finally, Autumn Glory Partners LLC acquired a new stake in Sabra Health Care REIT in the 4th quarter valued at about $173,000. 99.40% of the stock is owned by institutional investors.

Insider Activity

In other Sabra Health Care REIT news, Director Michael J. Foster sold 11,000 shares of Sabra Health Care REIT stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the transaction, the director now owns 64,725 shares of the company's stock, valued at $1,179,289.50. The trade was a 14.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.20% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Scotiabank upped their price objective on Sabra Health Care REIT from $18.00 to $19.00 and gave the company a "sector perform" rating in a research note on Monday, May 12th. Truist Financial raised their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a report on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $19.50.

Read Our Latest Research Report on Sabra Health Care REIT

Sabra Health Care REIT Stock Up 2.0%

Sabra Health Care REIT stock traded up $0.35 during midday trading on Friday, reaching $17.44. The stock had a trading volume of 2,710,400 shares, compared to its average volume of 2,202,522. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. Sabra Health Care REIT, Inc. has a 12 month low of $13.87 and a 12 month high of $20.03. The company has a fifty day moving average price of $17.52 and a two-hundred day moving average price of $17.39. The company has a market capitalization of $4.15 billion, a P/E ratio of 32.91, a PEG ratio of 1.97 and a beta of 0.88.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, topping the consensus estimate of $0.36 by $0.01. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. During the same period in the prior year, the business posted $0.35 earnings per share. The company's quarterly revenue was up 10.1% compared to the same quarter last year. As a group, equities analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Investors of record on Friday, May 16th will be issued a $0.30 dividend. The ex-dividend date is Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.88%. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 203.39%.

Sabra Health Care REIT Profile

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Recommended Stories

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Health Care REIT Right Now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines